title: Letter by Mehran et al regarding article, "Bleeding academic research consortium consensus report: the food and drug administration perspective".
authors.forename: Roxana
authors.initials: R
authors.lastname: Mehran
authors.forename: Philippe Gabriel
authors.initials: PG
authors.lastname: Steg
authors.forename: Harvey D
authors.initials: HD
authors.lastname: White
authors.forename: Sunil V
authors.initials: SV
authors.lastname: Rao
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects*; D004348:Drug Labeling / Q000592:standards*; D006470:Hemorrhage / Q000517:prevention & control*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D014486:United States Food and Drug Administration
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors